Cargando…
Loss of RAGE Defense: A Cause of Charcot Neuroarthropathy?
OBJECTIVE: This study investigated the relationship between circulating soluble receptor for advanced glycation end products (sRAGE) and parameters of bone health in patients with Charcot neuroarthropathy (CNA). RESEARCH DESIGN AND METHODS: Eighty men (aged 55.3 ± 9.0 years), including 30 healthy co...
Autores principales: | Witzke, Kara A., Vinik, Aaron I., Grant, Lisa M., Grant, William P., Parson, Henri K., Pittenger, Gary L., Burcus, Niculina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120187/ https://www.ncbi.nlm.nih.gov/pubmed/21593297 http://dx.doi.org/10.2337/dc10-2315 |
Ejemplares similares
-
An overview of Charcot’s neuroarthropathy
por: Dardari, Dured
Publicado: (2020) -
The pathogenesis of Charcot neuroarthropathy: current concepts
por: Larson, Shelly A. M., et al.
Publicado: (2012) -
Neuroarthropathy in diabetes: pathogenesis of Charcot arthropathy
por: Johnson-Lynn, S. E., et al.
Publicado: (2018) -
Controversies in the management of active Charcot neuroarthropathy
por: Gooday, Catherine, et al.
Publicado: (2023) -
Striving for clinical consensus in the management of Charcot’s neuroarthropathy
por: Rogers, Joseph
Publicado: (2011)